Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry.
about
Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Distinguishing Benign from Mal ...... omatography-Mass Spectrometry.
@en
Distinguishing Benign from Mal ...... omatography-Mass Spectrometry.
@nl
type
label
Distinguishing Benign from Mal ...... omatography-Mass Spectrometry.
@en
Distinguishing Benign from Mal ...... omatography-Mass Spectrometry.
@nl
prefLabel
Distinguishing Benign from Mal ...... omatography-Mass Spectrometry.
@en
Distinguishing Benign from Mal ...... omatography-Mass Spectrometry.
@nl
P2093
P2860
P356
P1433
P1476
Distinguishing Benign from Mal ...... omatography-Mass Spectrometry.
@en
P2093
Aalim M Weljie
Chad G Ball
Elijah Dixon
Francis R Sutherland
Hans J Vogel
Karen A Kopciuk
Yarrow J McConnell
P2860
P356
10.3390/METABO7010003
P577
2017-01-13T00:00:00Z